These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7684674)

  • 1. Congenital bleeding disorders. Rational treatment options.
    Seremetis SV; Aledort LM
    Drugs; 1993 Apr; 45(4):541-7. PubMed ID: 7684674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current therapy for rare factor deficiencies.
    Di Paola J; Nugent D; Young G
    Haemophilia; 2001 Jan; 7 Suppl 1():16-22. PubMed ID: 11240614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical care of patients with hereditary disorders of blood coagulation.
    Shulman NR
    Mod Treat; 1968 Jan; 5(1):61-83. PubMed ID: 4870180
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-thrombotic-, non-inhibitor-associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrand's disease: a systematic review of prospective studies.
    Franchini M; Makris M; Santagostino E; Coppola A; Mannucci PM
    Haemophilia; 2012 May; 18(3):e164-72. PubMed ID: 22250981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
    Asatiani E; Kessler CM;
    Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited bleeding disorders.
    Blanchette VS; Sparling C; Turner C
    Baillieres Clin Haematol; 1991 Apr; 4(2):291-332. PubMed ID: 1912663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peri-operative management of patients with coagulation disorders.
    Martlew VJ
    Br J Anaesth; 2000 Sep; 85(3):446-55. PubMed ID: 11103188
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress in the treatment of bleeding disorders.
    Bergman GE
    Thromb Res; 2011 Jan; 127 Suppl 1():S3-5. PubMed ID: 21035836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hepatitis C virus infection in children with haemophilia A and B and von Willebrand's disease.
    Kreuz W; Auerswald G; Brückmann C; Zieger B; Linde R; Funk M; Auberger K; Sutor AH; Rasshofer R; Roggendorf M
    Thromb Haemost; 1992 Jan; 67(1):184. PubMed ID: 1615476
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive care for hemophilia and other inherited bleeding disorders.
    Page D
    Transfus Apher Sci; 2019 Oct; 58(5):565-568. PubMed ID: 31427262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(1):19-25. PubMed ID: 7796372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of haemophilia A and B and von Willebrand's disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment.
    Berntorp E; Astermark J; Baghaei F; Bergqvist D; Holmström M; Ljungberg B; Norlund A; Palmblad J; Petrini P; Stigendal L; Säwe J
    Haemophilia; 2012 Mar; 18(2):158-65. PubMed ID: 22151198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired haemophilia in association with type III von Willebrand's disease: successful treatment with high purity von Willebrand's factor and recombinant factor VIIa.
    Majumdar G; Phillips JK; Lavallee H; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1035-7. PubMed ID: 8148477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors.
    Lethagen S; Ragnarson Tennvall G
    Ann Hematol; 1993 May; 66(5):257-60. PubMed ID: 8507721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No inhibitor development after continuous infusion of factor concentrates in subjects with bleeding disorders undergoing surgery: a prospective study.
    Auerswald G; Bade A; Haubold K; Overberg D; Masurat S; Moorthi C
    Haemophilia; 2013 May; 19(3):438-44. PubMed ID: 23279056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use and Future Investigations of Recombinant and Plasma-Derived Coagulation and Anticoagulant Products in the Neonate.
    Punzalan RC; Gottschall JL
    Transfus Med Rev; 2016 Oct; 30(4):189-96. PubMed ID: 27576087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of the spectrum of common and rare inherited coagulation disorders in north-eastern Iran.
    Mansouritorghabeh H; Manavifar L; Banihashem A; Modaresi A; Shirdel A; Shahroudian M; Shoja-E-Razavi G; Pousti H; Esmaily H
    Blood Transfus; 2013 Apr; 11(2):233-40. PubMed ID: 23114518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease.
    Josephson CD; Abshire TC
    Best Pract Res Clin Haematol; 2006; 19(1):35-49. PubMed ID: 16377540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.